This report provides an extensive study of the current market landscape and the likely future potential of the deep learning solutions market within the healthcare domain. It highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry and answers many key questions related to this domain. It also discusses the introduction of artificial intelligence, the next-generation simulator that employs programmed machines possessing the ability to learn from data and make decisions.